JP2021519311A5 - - Google Patents

Info

Publication number
JP2021519311A5
JP2021519311A5 JP2020551971A JP2020551971A JP2021519311A5 JP 2021519311 A5 JP2021519311 A5 JP 2021519311A5 JP 2020551971 A JP2020551971 A JP 2020551971A JP 2020551971 A JP2020551971 A JP 2020551971A JP 2021519311 A5 JP2021519311 A5 JP 2021519311A5
Authority
JP
Japan
Prior art keywords
seq
composition according
acid sequence
amino acid
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020551971A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519311A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/024854 external-priority patent/WO2019191598A1/en
Publication of JP2021519311A publication Critical patent/JP2021519311A/ja
Publication of JP2021519311A5 publication Critical patent/JP2021519311A5/ja
Pending legal-status Critical Current

Links

JP2020551971A 2018-03-29 2019-03-29 抗微生物性バクテリオファージ由来ポリペプチド及びグラム陰性細菌に対するそれらの使用 Pending JP2021519311A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862650235P 2018-03-29 2018-03-29
US62/650,235 2018-03-29
PCT/US2019/024854 WO2019191598A1 (en) 2018-03-29 2019-03-29 Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative bacteria

Publications (2)

Publication Number Publication Date
JP2021519311A JP2021519311A (ja) 2021-08-10
JP2021519311A5 true JP2021519311A5 (cg-RX-API-DMAC7.html) 2022-04-01

Family

ID=68058481

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020551971A Pending JP2021519311A (ja) 2018-03-29 2019-03-29 抗微生物性バクテリオファージ由来ポリペプチド及びグラム陰性細菌に対するそれらの使用

Country Status (11)

Country Link
US (1) US20210330738A1 (cg-RX-API-DMAC7.html)
EP (1) EP3773669A4 (cg-RX-API-DMAC7.html)
JP (1) JP2021519311A (cg-RX-API-DMAC7.html)
KR (1) KR20210005027A (cg-RX-API-DMAC7.html)
CN (1) CN112368010A (cg-RX-API-DMAC7.html)
AU (1) AU2019245333A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020019010A2 (cg-RX-API-DMAC7.html)
CA (1) CA3096236A1 (cg-RX-API-DMAC7.html)
IL (1) IL277399A (cg-RX-API-DMAC7.html)
MX (1) MX2020010071A (cg-RX-API-DMAC7.html)
WO (1) WO2019191598A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019191633A2 (en) 2018-03-29 2019-10-03 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
MX2021015563A (es) * 2019-07-05 2022-03-17 Contrafect Corp Polipéptidos anti-microbianos, derivados de bacteriófago, y sus usos contra bacterias gramnegativas y acidorresistentes.
JP2023502940A (ja) * 2019-11-14 2023-01-26 コントラフェクト コーポレイション 溶解素-抗微生物ペプチド(amp)ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用
WO2021211303A1 (en) * 2020-04-14 2021-10-21 Contrafect Corporation Antiviral, bacteriophage-derived polypeptides and their use against viruses
CU24750B1 (es) * 2020-11-19 2025-06-11 Centro De Investig Y Desarrollo De Medicamentos Cidem Entidades peptídicas con actividad antimicrobiana frente a patógenos multi-drogoresistentes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2447823A1 (en) * 2001-05-23 2002-11-28 The University Of British Columbia Diagnosis of vascular disease susceptibility using bacteriophage phi-cpn1 host chlamydia
US8022271B2 (en) * 2003-05-16 2011-09-20 North Carolina State University Polyubiquitin Rubi3 promoter and 5' regulatory sequences
US8067532B2 (en) * 2007-01-19 2011-11-29 Kai Pharmaceuticals, Inc. Modifications of peptide compositions to increase stability and delivery efficiency
WO2010141135A2 (en) * 2009-03-05 2010-12-09 Trustees Of Boston University Bacteriophages expressing antimicrobial peptides and uses thereof
SG11201405721VA (en) * 2012-03-19 2014-10-30 Madeleine Pharmaceuticals Ρτy Ltd Method of producing a recombinant peptide
ES2934714T3 (es) * 2015-09-17 2023-02-24 Contrafect Corp Polipéptidos de lisina activos contra bacterias Gram-negativas
WO2019191633A2 (en) * 2018-03-29 2019-10-03 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
EP3840771A4 (en) * 2018-08-23 2023-04-19 Contrafect Corporation POLYPEPTIDE CONSTRUCTS WITH LYSINE ANTIMICROBIAL PEPTIDE (AMP), LYSINE, ISOLATED POLYNUCLEOTIDES ENCODING THEREOF AND USES THEREOF
MX2021015563A (es) * 2019-07-05 2022-03-17 Contrafect Corp Polipéptidos anti-microbianos, derivados de bacteriófago, y sus usos contra bacterias gramnegativas y acidorresistentes.
JP2023502940A (ja) * 2019-11-14 2023-01-26 コントラフェクト コーポレイション 溶解素-抗微生物ペプチド(amp)ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用
US20210324359A1 (en) * 2020-04-17 2021-10-21 Contrafect Corporation Use of gram-negative lysin-antimicrobial peptide (amp) polypeptide constructs in treating endocarditis

Similar Documents

Publication Publication Date Title
JP2021519083A5 (cg-RX-API-DMAC7.html)
IL277119B1 (en) Antimicrobial lysine-peptide polypeptide templates, lysines, isolated polynucleotides encoding them and uses thereof
JP2021506769A5 (cg-RX-API-DMAC7.html)
US20250064902A1 (en) Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
JP2024010053A5 (cg-RX-API-DMAC7.html)
JP2021533728A5 (cg-RX-API-DMAC7.html)
JP2023517245A5 (cg-RX-API-DMAC7.html)
US20190345467A1 (en) Acinetobacter lysins
WO2010141135A2 (en) Bacteriophages expressing antimicrobial peptides and uses thereof
CN112218659A (zh) 用于治疗葡萄球菌感染的治疗性噬菌体组合物
RU2020128276A (ru) МОДИФИЦИРОВАННЫЕ ЛИЗИНЫ PlySs2 И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ
JP2022539383A5 (cg-RX-API-DMAC7.html)
JP2021513865A5 (cg-RX-API-DMAC7.html)
JP2021508501A (ja) Pseudomonas感染症を処置するためのバクテリオファージ組成物
JP2022526978A5 (cg-RX-API-DMAC7.html)
JP2023502940A5 (cg-RX-API-DMAC7.html)
RU2020131450A (ru) Происходящие из бактериофагов противомикробные полипептиды и их применение против грамотрицательных бактерий
AU2004212179A1 (en) Antimicrobial agents from Streptococcus mitis and Streptococcus oralis
KR101595976B1 (ko) 황색포도알균에 특이적 항균 활성을 가지는 리신 융합 단백질 및 이의 용도
RU2021137156A (ru) Происходящие из бактериофагов противомикробные полипептиды и их применение против грамотрицательных и кислотоустойчивых бактерий
RU2020118691A (ru) Идентификация лизинов и их производных, обладающих антибактериальной активностью против pseudomonas aeruginosa
US12606640B2 (en) Recombinant antimicrobial multidomain polypeptide, methods of producing and uses thereof
US20220387563A1 (en) Novel polypeptides and antibiotics against Gram-negative bacterium comprising the same
RU2022126282A (ru) Новый рекомбинантный лизин и его применение в лечении грамотрицательных бактериальных инфекций
HK40086790A (en) Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby